We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
HLN

Price
10.06
Stock movement up
+0.43 (4.47%)
Company name
Haleon plc
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
45.49B
Ent value
61.64B
Price/Sales
3.99
Price/Book
2.72
Div yield
1.02%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
30.04
Forward P/E
26.93
PEG
-
EPS growth
-
1 year return
23.13%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-04-11

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

HLN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E30.04
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.99
Price to Book2.72
EV to Sales5.40

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count4.52B
EPS (TTM)0.16
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)11.41B
Gross profit (TTM)7.19B
Operating income (TTM)2.40B
Net income (TTM)1.51B
EPS (TTM)0.16
EPS (1y forward)0.37

Margins

Loading...
Margins data
Gross margin (TTM)62.99%
Operating margin (TTM)21.07%
Profit margin (TTM)13.27%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash531.00M
Net receivables2.14B
Total current assets4.71B
Goodwill0.00
Intangible assets26.37B
Property, plant and equipment1.86B
Total assets33.40B
Accounts payable3.60B
Short/Current long term debt8.86B
Total current liabilities5.62B
Total liabilities16.69B
Shareholder's equity16.71B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)0.00
Capital expenditures (TTM)0.00
Free cash flow (TTM)0.00
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity9.06%
Return on Assets4.53%
Return on Invested Capital5.94%
Cash Return on Invested Capital-
Haleon plc (NYSE:HLN) Q4 2024 Earnings Conference Call February 27, 2025 4:00 AM ETCompany ParticipantsJo Russell - Head-Investor RelationsBrian McNamara -...
February 27, 2025

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open9.85
Daily high10.06
Daily low9.82
Daily Volume16.2M
All-time high10.69
1y analyst estimate10.76
Beta0.24
EPS (TTM)0.16
Dividend per share0.10
Ex-div date16 Aug 2024
Next earnings date-

Downside potential

Loading...
Downside potential data
HLNS&P500
Current price drop from All-time high-5.89%-12.89%
Highest price drop-24.83%-56.47%
Date of highest drop2 Sep 20229 Mar 2009
Avg drop from high-7.15%-11.07%
Avg time to new high16 days12 days
Max time to new high317 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
HLN (Haleon plc) company logo
Marketcap
45.49B
Marketcap category
Large-cap
Description
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Employees
25408
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Semi-annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...